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ABSTRACT 
The aim of present study was to prepare sustained release tablet of Theophylline so as to prolong its elimination time and at the same time to 
keep cost of the formulation minimum. In this study ethyl cellulose and Eudragit are used in the formulation to sustain the release of 
Theophylline. Ethyl cellulose and Eudragit are added at the granulation step to form a sustained release coating around each granule. Different 
batches were designed one after another on trial and error basis to get the optimum drug release upto 12 hours. 
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For decades acute disease and chronic illness is being 
clinically treated through delivery of drugs to patients in the 
form of tablets, capsules, pills, creams, liquids, ointments, 
aerosols, injectables and suppositories. To maintain the 
concentration of an administered drug within 
therapeutically effective range, it is required to take drug 
dosage several times and this result in fluctuations in plasma 
drug concentration1. This can be overcome by formulation of 
sustained release dosage form which gives drug release in an 
amount sufficient to maintain therapeutic drug level over 
extended period of time. As a result sustained release 
formulations are preferred for drugs which are administered 
orally and have high dosing frequency2, 3.  
Theophylline has long being used as a treatment for diseases, 
including bronchial asthma. However, as its therapeutic 
concentration range is narrow, and its absorption is prone to 
the effects of meals, the dosing management of the drug has 
been difficult. The drug release rate is difficult to control in a 
sustained release tablets. Moreover, as they are 
manufactured by a complicated process, the drug release 
rate is likely to vary among lots, and advanced processing is 
needed to ensure consistent quality. Drug absorption from a 
conventional matrix tablet is influenced heavily by its 
transition rate in the GI tract, and accordingly, the 
bioavailability of conventional matrix tablet varies widely. It 
is the purpose of this study to develop a new dosage form 
that overcomes these biological and technological problems4, 
5, 6. 
In this study sustained release granules of theophylline were 
prepared, using granulation method. Unlike film coating, no 
expensive instrument was used.    
MATERIALS & METHODS  
Materials: Theophylline anhydrous, Ethyl Cellulose, 
Eudragit L100, Polyvinyl Pyrrolidione(K-30), Magnesium 
Stearate, Talc, Isopropyl Alcohol, Dichloromethane, Acetone. 
Preparation of sustained release tablet of Theophylline 
anhydrous: 
Sustained release tablets of Theophylline were prepared by 
wet granulation method. Different quantities of different 
polymers (Table 1) were dissolved in respective solvents 
and the resulting solution was added slowly to 20# passed 
Theophylline blend in Kenwood granulator. In present study 
ethyl cellulose was added at the granulation step in 
solubilized form. This results in application of ethyl cellulose 
at molecular level to form water insoluble coat around 
granule. The resulting granules were dried in Rapidrier at 
30-400C till LOD becomes below 2.5%. Dried granules were 
passed through 20# and mixed with magnesium Stearate 
and talc. Tablets were prepared from these granules using 16 
station rotary tablets compression machine. 
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Table 1: Formulation and composition of SR tablet of Theophylline anhydrous 
     Ingredients                                        Batch No 
F1 F2 F3 F4 F5 F6 F7 
TP 250 250 250 250 250 250 250 
EC(20cps for F1, F2 & 7cps for F3- F7) 1 2 1 3 2 1.6 1.8 
PVP K-30 5 8 - - - - - 
IPA qs qs qs qs qs qs qs 
MDC qs qs qs qs qs qs qs 
Talc 2 2 2 2 2 2 2 
Mag. Stearate 2 2 2 2 2 2 2 
Eudragit L-100 - - 15 10 13 14 13 
TP- Theophylline anhydrous, EC - ethyl cellulose, PVP K-30 – Polyvinylpyrolidone, IPA - isopropyl alcohol, MDC - methylene dichloride,  qs- 
quantity sufficient. 
 
Evaluation of granule and powder properties 7, 8, 9: 
To determine physicochemical properties and release 
characteristics of the granules, all formulations are subjected 
to pre-formulation studied like Angle of repose, void volume, 
porosity.  
Evaluation of compressed tablets 7, 8, 9, 10: 
Prepared tablets were evaluated for Thickness, hardness, 
friability, weight variation, disintegration and dissolution. 
Weight variation: 
Weight variation was performed by weighing 20 tablets 
individually, taking average weight and comparing individual 
weight with the average weight. 
Hardness:  
Hardness of randomly selected tablets was determined by 
Erweka hardness tester. Hardness was measured in 
Newtons. 
Friability: 
Friability was determined by first weighing 10 tablets before 
placing in Roche friabilator, which was then rotated for 4 
minutes at 25 rpm. After dusting tablets were reweighed. 
Disintegration: 
Disintegration test was performed by introducing one tablet 
in each tube and then suspending the basket assembly in a 
beaker containing purified water and operating the 
apparatus until tablet disintegrates completely. 
In-Vitro Dissolution test: 
In-vitro dissolution studies were carried out using USP XXI 
Dissolution Test Apparatus Type II at 50 rpm. Dissolution 
test was carried out for the period of 12 hours using 0.1N 
HCl (pH 1.2) solution as a dissolution medium at 37 ± 0.50 C 
for one hour and Phosphate Buffer (pH-6.8) for rest of the 
time. 5ml sample was withdrawn at predetermined time 
interval up to 12 hours and replaced with same volume of 
fresh dissolution medium. The withdrawn samples were 
analyzed by SHIMADZU UV spectrophotometer at 274 nm 
using Phosphate Buffer as a blank. Percentage cumulative 
drug release was calculated. 
RESULTS AND DISCUSSION 
Pre compression parameters: As shown in table 2, the 
angle of repose for all formulations fell within the range of 
27–350 indicating good flow properties. Bulk density values 
of all theophylline formulations fell in the range of 0.35-0.5 
g/cm3 indicating good packing capacity. 
 
Table 2: Powder properties of different formulations 





F1 30.17 0.457 1.3 27 
F2 30.31 0.442 1.7 32 
F3        32.13 0.532 1.6 26 
F4 29.12 0.567 1.3 27 
F5 31.29 0.439 1.7 29 
F6 34.32 0.547 1.4 26 
F7 33.57 0.522 1.6 27 
 
Post compression parameters: 
All the theophylline formulations were evaluated for various 
parameters; observations are depicted in Table 3. 
The % deviation in weights of tablets was + 5% which is 
within the range according to IP. This shows uniform die fill 
during tablet compression. The tablets were analyzed for 
potency. The drug content was in range of 98-103% showing 
uniform distribution of drug in tablet. 
As there was no much variation in thickness of tablets in 
each formulation, it shows that granules and powder blends 
were consistent in particle size and uniform behavior during 
compression process. The hardness of tablet was measured 
by Erweka hardness tester. The tablet hardness was in the 
range of 110 – 123 N. Friability was found to be 0.2 – 0.3 %. 
As friability was below 0.8 %, tablets in each formulation can 




Gaware et al                                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(1-s):48-51 
ISSN: 2250-1177                                                                                  [50]                                                                                 CODEN (USA): JDDTAO 
Table 3: Tablet properties of theophylline formulations 
Formulation Average 
weight(mg) 
Thickness(mm) % drug 
content 
Hardness(N) % Friability 
F1 265 3.82 99.33 113 0.23 
F2 263 3.81 98.63 110 0.25 
F3 271 3.83 103.83 120 0.26 
F4 267 3.82 101.13 121 0.34 
F5 265 3.81 103.59 125 0.35 
F6 270 3.83 102.7 107 0.26 
F7 268 3.82 101.6 114 0.31 
 
In-vitro dissolution studies: 
Table 4: Cumulative % Drug Release (%CDR) 
Time(hrs)                             Cumulative %  Drug Release (% CDR) 
F1 F2 F3 F4 F5 F6 F7 
1 22.9 23.3 18.5 17.6 17.7 17.0 17.4 
2 35.7 34.0 56.1 25.2 25.7 33.8 28.1 
4 49.7 46.5 101.3 33.9 47.6 60.7 47.8 
8 68.9 64.8 103.5 49.0 70.7 93.6 77.3 
12 82.7 77.9 105.2 62.8 87.4 99.6 96.9 
 
 
Figure 1: In-vitro dissolution profile F1-F3 
 
Figure 2: In-vitro dissolution profile F4-F7. 
F1 & F2 showed very slow drug release (82% & 77% after 12 
hours) due to use of EC (20cps) in wet granulation. Since EC 
is solubilized in granulating solvent it gets applied to 
granules at molecular level. Degree of formation of film 
around granules is more when EC is applied at molecular 
level11. 
According to Percolation theory, when matrix is composed of 
water soluble drug and a water insoluble polymer, drug 
release occurs by dissolution of the active ingredient through 
capillaries composed of interconnecting drug particle 
clusters and the pore network. The total number of EC 
molecules surrounding granules increases when EC is 
applied at molecular level. When more EC particles present 
the fewer clusters of soluble drug substance are formed. Due 
to this pore network becomes less extensive and more 
torturous resulting in slower drug release12. 
As the drug release rate was found to be slower with EC 
(20cps), EC of 7 cps was used in next formulation. In addition 
to EC it was found that PVP K-30 produces harder granules, 
which upon coating with EC resist the drug release for longer 
time. These harder granules do not allow the erosion of the 
tablet for the drug release. To control the drug release in first 
hour that is in acidic media, an enteric polymer (Eudragit L-
100) was used in next formulations instead of PVP K-30. 
F3 showed faster drug release (56% after 2 hours and 101% 
after 4 hours) since tablet eroded completely after 3 hours. 
Therefore to maintain the structural integrity of tablet, EC 
concentration was increased and thereafter it was optimized 
along with concentration of Eudragit in the next 
formulations until desired drug release pattern was 
obtained. 
CONCLUSION 
Conclusion can be drawn from the present investigation that, 
a combination of hydrophobic polymer and enteric polymer 
can be used successfully for sustained release tablets of 
theophylline. Optimized formulation containing ethyl 
cellulose and Eudragit had successfully sustained the drug 
release up to 12 hours. Thus the sustained release tablet of 
theophylline can be using biocompatible polymers can be 
formulated, evaluated and found to be suitable candidate for 
prolonging the release of theophylline. 
AKNOWLEDGEMENT 
The authors gratefully acknowledge the contributions of Dr. 
D. D Gaikwad and Dr. S. L. Jadhav, CEO & Principal VIPER, Ale 
respectively for constant motivation and encouragement.  
CONFLICT OF INTEREST 





































Gaware et al                                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(1-s):48-51 
ISSN: 2250-1177                                                                                  [51]                                                                                 CODEN (USA): JDDTAO 
REFERENCES 
1. Vyas SP and Khar RK, Controlled Drug Delivery, Concepts and 
Advances, 2002; First edition, Vallabh Prakashan, Delhi: 1-2, 
10-12, 156-160. 
2. Wise DL, Handbook of Pharmaceutical Controlled Release 
Technology, 2005; Marcel Dekker, INC., New York and Basel: 
211, 435-440, 472-473, and 787-788. 
3. Tetsuo B. and Kanbe S., Formulation study and drug release 
mechanism of new theophylline sustained release 
preparation, Int. J. Pharm. 2005; 304:91-101. 
4. Yasim K. and Gokhan R., Different geometric shaped hydrogel 
theophylline tablets: Statistical approach for estimating drug 
release, Farmaco 2002; 57:939-945. 
5. Lin F. and Wang H., Influence of plasticizers on the release of 
theophylline from micro porous-controlled tablets, J. Cont. 
Rel. 2004; 99:415-421. 
6. Ali F. and Anish N., In situ cross-linking of sodium alginate 
with calcium and aluminium ions so as to sustain the release 
of theophylline from polymeric matrices, II Farmaco 2004; 
59:999-1004. 
7. Aulton ME. Pharmaceutics, The Science of Dosage form 
Design, 1998, 1st Edition. Churchill Livingstone.247-248, 603-
606. 
8. Martin’s Physical Pharmacy and Pharmaceutical sciences, 
1991, 3rd Edn., Varghese Publishing House, Bombay, 512-516. 
9. Shimona B. and Garic P., Bioadhesive grafted starch 
copolymers as platforms for peroral delivery: a study of 
theophylline release, J. Cont. Rel. 2004; 94:391-394.  
10. Karasulu H. and Ertan C., Modeling of theophylline release 
from different geometrical erodible tablets, Eu. J. Pharm. & 
Biopharm. 2000; 49:177-182. 
11. Gul R. and Jia N., Ibuprofen release kinetics from controlled-
release tablets granulated with aqueous polymeric dispersion 
of ethyl cellulose II: influence of several parameters and 
coexcipients, J. Cont. Rel. 1998; 56:127-134. 
12. Michael M. and Britta P., Physicochemical properties and 
mechanism of drug release and from ethyl cellulose matrix 
tablets prepared by direct compression and hot-melt 
extrusion, Int. J. Pharm. 2004; 269:509-522. 
 
 
 
 
